1. Home
  2. RNST vs AMPH Comparison

RNST vs AMPH Comparison

Compare RNST & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$35.36

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.31

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
AMPH
Founded
1904
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RNST
AMPH
Price
$35.36
$26.31
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$43.17
$31.00
AVG Volume (30 Days)
510.4K
367.6K
Earning Date
01-27-2026
11-06-2025
Dividend Yield
2.60%
N/A
EPS Growth
N/A
N/A
EPS
1.84
2.27
Revenue
$775,309,000.00
$723,305,000.00
Revenue This Year
$43.37
$1.35
Revenue Next Year
$13.13
$5.10
P/E Ratio
$19.27
$11.66
Revenue Growth
13.04
N/A
52 Week Low
$26.97
$20.39
52 Week High
$40.40
$39.01

Technical Indicators

Market Signals
Indicator
RNST
AMPH
Relative Strength Index (RSI) 40.88 49.11
Support Level $36.84 $26.26
Resistance Level $36.33 $27.23
Average True Range (ATR) 0.57 0.77
MACD -0.23 -0.00
Stochastic Oscillator 19.08 52.68

Price Performance

Historical Comparison
RNST
AMPH

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: